Suspended
Cognitive Correlates of Substance Abuse, Part 2 - 16
0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected
Data Collection
Who is being recruted
Amphetamine-Related Disorders
See all eligibility criteria
How is the trial designed
Other
Observational
See protocol details
Summary
Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 11, 2017
Sourced from a government-validated database.Claim as a partner
Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals. Part II: Examine cognitive performance of stimulant abusers (methamphetamine and cocaine) during recovery by assessing their cognitive function at monthly intervals.
Principal SponsorNational Institute on Drug Abuse (NIDA)
Last updated: January 11, 2017
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
43 patients to be enrolledTotal number of participants that the clinical trial aims to recruit.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Conditions
Criteria
Any sexBiological sex of participants that are eligible to enroll.
Healthy volunteers not allowedIf individuals who are healthy and do not have the condition being studied can participate.
Conditions
Pathology
Amphetamine-Related Disorders
Criteria
Ensure optimum compatibilityAdd your profile to know your probability eligibility score.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Suspended
SuspendedOne Study Center